{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:16:13Z","timestamp":1788254173251,"version":"build-2803163510"},"reference-count":112,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Leucine-rich repeat kinase 2 (LRRK2) has emerged as a central molecular node linking genetic risk, membrane trafficking, lysosomal homeostasis, and immune signalling in Parkinson\u2019s disease (PD). Rather than functioning as a conventional protein kinase, LRRK2 operates as a conformationally regulated, Rab-directed signalling machine whose activity is governed by long-range interdomain communication, membrane recruitment, and cooperative interactions with small GTPases. Converging advances in cryo-electron microscopy, quantitative phosphoproteomics, and human genetics indicate that pathogenic mutations, lysosomal stress, and pharmacological inhibitors do not simply alter catalytic output, but reshape the conformational landscape of LRRK2, biasing it toward distinct structural states with divergent cellular consequences. A defining feature of this system is the selective phosphorylation of Rab GTPases at low stoichiometry\u2014most prominently Rab8 and Rab10\u2014yet with disproportionate functional impact on vesicle trafficking, ciliogenesis, autophagy, and organelle positioning. The identification of Rab-directed phosphatases, particularly PPM1H, further establishes that LRRK2 signalling is governed by a dynamically balanced kinase\u2013phosphatase circuit operating in space and time. These observations, together with emerging evidence linking LRRK2 activation to lysosomal damage and immune pathways, support a unifying hypothesis: PD-associated LRRK2 dysfunction arises from maladaptive stabilization of specific conformational and spatial states within a membrane-responsive signalling network, leading to persistent misregulation of Rab-dependent trafficking and organelle homeostasis, rather than from kinase hyperactivity alone. In this review, we integrate structural, biochemical, and cellular evidence to advance this framework and discuss its implications for disease mechanisms and therapy. We highlight key unresolved challenges\u2014including conformation-selective drug targeting, spatial control of Rab phosphorylation, and context-dependent immune\u2013neuronal crosstalk\u2014and propose that restoring physiological regulation of LRRK2, rather than simply inhibiting its activity, will be essential for achieving mechanism-based disease modification in Parkinson\u2019s disease.<\/jats:p>","DOI":"10.3390\/ijms27177606","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:27:19Z","timestamp":1787657239000},"page":"7606","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LRRK2: Molecular Mechanisms in Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9982-7571","authenticated-orcid":false,"given":"Oscar","family":"Arias-Carri\u00f3n","sequence":"first","affiliation":[{"name":"Divisi\u00f3n de Neurociencias, Cl\u00ednica, Instituto Nacional de Rehabilitaci\u00f3n Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico"},{"name":"Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Mexico City 14380, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Guerra-Crespo","sequence":"additional","affiliation":[{"name":"Laboratory of Regenerative Medicine, Department of Physiology, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7443-2514","authenticated-orcid":false,"given":"Daniel","family":"Ortu\u00f1o-Sahag\u00fan","sequence":"additional","affiliation":[{"name":"Laboratorio de Neuroinmunobiolog\u00eda Molecular, Instituto de Neurociencias Traslacionales, CUCS, Universidad de Guadalajara, Guadalajara 44350, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-2253","authenticated-orcid":false,"given":"Emmanuel","family":"Ortega-Robles","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Neurociencias, Cl\u00ednica, Instituto Nacional de Rehabilitaci\u00f3n Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson\u2019s Disease","volume":"44","author":"Jain","year":"2004","journal-title":"Neuron"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson\u2019s disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson\u2019s Disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.cell.2021.03.048","article-title":"Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome","volume":"184","author":"Bourdenx","year":"2021","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-biochem-030122-051144","article-title":"Leucine-Rich Repeat Kinases","volume":"93","author":"Alessi","year":"2024","journal-title":"Annu. Rev. Biochem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neuroscience.2007.10.062","article-title":"Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson\u2019s disease","volume":"152","author":"Westerlund","year":"2008","journal-title":"Neuroscience"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Giesert, F., Hofmann, A., B\u00fcrger, A., Zerle, J., Kloos, K., Hafen, U., Ernst, L., Zhang, J., Vogt-Weisenhorn, D.M., and Wurst, W. (2013). Expression Analysis of Lrrk1, Lrrk2 and Lrrk2 Splice Variants in Mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063778"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/cne.23583","article-title":"Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents","volume":"522","author":"West","year":"2014","journal-title":"J. Comp. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00702-011-0653-2","article-title":"Parkinson\u2019s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures","volume":"118","author":"Hakimi","year":"2011","journal-title":"J. Neural Transm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41586-020-2673-2","article-title":"Structure of LRRK2 in Parkinson\u2019s disease and model for microtubule interaction","volume":"588","author":"Deniston","year":"2020","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"eadk6191","DOI":"10.1126\/sciadv.adk6191","article-title":"Inhibition of Parkinson\u2019s disease\u2013related LRRK2 by type I and type II kinase inhibitors: Activity and structures","volume":"9","author":"Dederer","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1126\/science.adi9926","article-title":"Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2","volume":"382","author":"Zhu","year":"2023","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e12813","DOI":"10.7554\/eLife.12813","article-title":"Phosphoproteomics reveals that Parkinson\u2019s disease kinase LRRK2 regulates a subset of Rab GTPases","volume":"5","author":"Steger","year":"2016","journal-title":"eLife"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1074\/mcp.RA120.002055","article-title":"Accurate MS-based Rab10 Phosphorylation Stoichiometry Determination as Readout for LRRK2 Activity in Parkinson\u2019s Disease","volume":"19","author":"Karayel","year":"2020","journal-title":"Mol. Cell. Proteom."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"eaav0820","DOI":"10.1126\/scitranslmed.aav0820","article-title":"LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits","volume":"12","author":"Baptista","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e50416","DOI":"10.7554\/eLife.50416","article-title":"PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins","volume":"8","author":"Berndsen","year":"2019","journal-title":"eLife"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"E9115","DOI":"10.1073\/pnas.1812196115","article-title":"LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis","volume":"115","author":"Eguchi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"EMBJ2020104494","DOI":"10.15252\/embj.2020104494","article-title":"LRRK2 activation controls the repair of damaged endomembranes in macrophages","volume":"39","author":"Herbst","year":"2020","journal-title":"EMBO J."},{"key":"ref_20","first-page":"1","article-title":"Role of Lysosomal Genes for Parkinson\u2019s Pathogenesis: Insights from Molecular Mechanism to Therapeutic Strategies","volume":"21","author":"Amit","year":"2026","journal-title":"Curr. Rev. Clin. Exp. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1016\/j.cell.2021.05.004","article-title":"Structural analysis of the full-length human LRRK2","volume":"184","author":"Myasnikov","year":"2021","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"eadt2050","DOI":"10.1126\/sciadv.adt2050","article-title":"Type II kinase inhibitors that target Parkinson\u2019s disease\u2013associated LRRK2","volume":"11","author":"Raig","year":"2025","journal-title":"Sci. Adv."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Weng, J.-H., Aoto, P.C., Lorenz, R., Wu, J., Schmidt, S.H., Manschwetus, J.T., Kaila-Sharma, P., Silletti, S., Mathea, S., and Chatterjee, D. (2022). LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domains. PLoS Biol., 20, Correction in PLoS Biol.\u00a02025, 23, e3003017. https:\/\/doi.org\/10.1371\/journal.pbio.3003017.","DOI":"10.1371\/journal.pbio.3003017"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1042\/BCJ20220161","article-title":"Impact of 100 LRRK2 variants linked to Parkinson\u2019s disease on kinase activity and microtubule binding","volume":"479","author":"Kalogeropulou","year":"2022","journal-title":"Biochem. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.cell.2020.08.004","article-title":"The In Situ Structure of Parkinson\u2019s Disease-Linked LRRK2","volume":"182","author":"Watanabe","year":"2020","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41594-022-00863-y","article-title":"Structural basis for Parkinson\u2019s disease-linked LRRK2\u2019s binding to microtubules","volume":"29","author":"Snead","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"RP100799","DOI":"10.7554\/eLife.100799","article-title":"Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2","volume":"13","author":"Chen","year":"2025","journal-title":"eLife"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"110376","DOI":"10.1016\/j.jbc.2025.110376","article-title":"Structural biology of Parkinson\u2019s disease-associated leucine-rich repeat kinase 2 (LRRK2)","volume":"301","author":"Leschziner","year":"2025","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","article-title":"Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin","volume":"23","author":"Greggio","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbrc.2007.04.006","article-title":"The R1441C mutation of LRRK2 disrupts GTP hydrolysis","volume":"357","author":"Lewis","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1523\/JNEUROSCI.3730-10.2011","article-title":"LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool","volume":"31","author":"Piccoli","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"eabb2454","DOI":"10.1126\/sciadv.abb2454","article-title":"LRRK2 mediates tubulation and vesicle sorting from lysosomes","volume":"6","author":"Beilina","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"112448","DOI":"10.1016\/j.celrep.2023.112448","article-title":"Regulatory imbalance between LRRK2 kinase, PPM1H phosphatase, and ARF6 GTPase disrupts the axonal transport of autophagosomes","volume":"42","author":"Dou","year":"2023","journal-title":"Cell Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: A case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/mds.26614","article-title":"Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson\u2019s disease","volume":"31","author":"Marras","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/jamaneurol.2014.1909","article-title":"Disease Penetrance of Late-Onset Parkinsonism: A Meta-analysis","volume":"71","author":"Trinh","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mds.27059","article-title":"Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry","volume":"32","author":"Lee","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e40202","DOI":"10.7554\/eLife.40202","article-title":"A pathway for Parkinson\u2019s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain","volume":"7","author":"Dhekne","year":"2018","journal-title":"eLife"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/brain\/awae142","article-title":"Parkinson\u2019s disease variant detection and disclosure: PD GENEration, a North American study","volume":"147","author":"Cook","year":"2024","journal-title":"Brain"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamaneurol.2017.4019","article-title":"Progression in the LRRK2-Associated Parkinson Disease Population","volume":"75","author":"Mirelman","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","article-title":"Clinical Correlations with Lewy Body Pathology in LRRK2-Related Parkinson Disease","volume":"72","author":"Kalia","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/mds.27974","article-title":"Penetrance of Parkinson\u2019s Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score","volume":"35","author":"Iwaki","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/mds.27601","article-title":"LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson\u2019s disease patients","volume":"34","author":"Atashrazm","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mds.29297","article-title":"LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson\u2019s Disease","volume":"38","author":"Jennings","year":"2023","journal-title":"Mov. Disord."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"eaar5429","DOI":"10.1126\/scitranslmed.aar5429","article-title":"LRRK2 activation in idiopathic Parkinson\u2019s disease","volume":"10","author":"Hoffman","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00439-008-0544-2","article-title":"LRRK2 R1628P increases risk of Parkinson\u2019s disease: Replication evidence","volume":"124","author":"Tan","year":"2008","journal-title":"Hum. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neulet.2016.04.056","article-title":"The association between the LRRK2 R1628P variant and the risk of Parkinson\u2019s disease in Asian: A meta-analysis","volume":"623","author":"Wang","year":"2016","journal-title":"Neurosci. Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20100483","article-title":"14-3-3 binding to LRRK2 is disrupted by multiple Parkinson\u2019s disease-associated mutations and regulates cytoplasmic localization","volume":"430","author":"Nichols","year":"2010","journal-title":"Biochem. J."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Li, X., Wang, Q.J., Pan, N., Lee, S., Zhao, Y., Chait, B.T., and Yue, Z. (2011). Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson\u2019s Disease. PLoS ONE, 6, Correction in PLoS ONE\u00a02011, 6, 10.1371\/annotation\/e66e7e90-9503-46b8-91f9-abe4d5056ba1.","DOI":"10.1371\/annotation\/e66e7e90-9503-46b8-91f9-abe4d5056ba1"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1042\/BST20120137","article-title":"Pharmacological inhibition of LRRK2 cellular phosphorylation sites provides insight into LRRK2 biology","volume":"40","author":"Zhao","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddi439","article-title":"The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity","volume":"15","author":"Gloeckner","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"164ra161","DOI":"10.1126\/scitranslmed.3004485","article-title":"Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations","volume":"4","author":"Sheng","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e79771","DOI":"10.7554\/eLife.79771","article-title":"A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation","volume":"11","author":"Vides","year":"2022","journal-title":"eLife"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1471-4159.2010.07105.x","article-title":"Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant","volume":"116","author":"Vancraenenbroeck","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.21405","article-title":"Analysis of Lrrk2 R1628P as a risk factor for Parkinson\u2019s disease","volume":"64","author":"Ross","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Shu, L., Zhang, Y., Sun, Q., Pan, H., and Tang, B. (2019). A Comprehensive Analysis of Population Differences in LRRK2 Variant Distribution in Parkinson\u2019s Disease. Front. Aging Neurosci., 11.","DOI":"10.3389\/fnagi.2019.00013"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1038\/ncomms6827","article-title":"Phosphorylation of LRRK2 by casein kinase 1\u03b1 regulates trans-Golgi clustering via differential interaction with ARHGEF7","volume":"5","author":"Chia","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1471-4159.2011.07537.x","article-title":"Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson\u2019s disease mutations and LRRK2 pharmacological inhibition","volume":"120","author":"Doggett","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/BJ20141305","article-title":"LRRK2 dephosphorylation increases its ubiquitination","volume":"469","author":"Zhao","year":"2015","journal-title":"Biochem. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrm2728","article-title":"Rab GTPases as coordinators of vesicle traffic","volume":"10","author":"Stenmark","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1042\/BCJ20180248","article-title":"The Parkinson\u2019s disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human","volume":"475","author":"Mir","year":"2018","journal-title":"Biochem. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e67900","DOI":"10.7554\/eLife.67900","article-title":"Pathogenic LRRK2 control of primary cilia and Hedgehog signaling in neurons and astrocytes of mouse brain","volume":"10","author":"Khan","year":"2021","journal-title":"eLife"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e31012","DOI":"10.7554\/eLife.31012","article-title":"Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis","volume":"6","author":"Steger","year":"2017","journal-title":"eLife"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.str.2020.01.005","article-title":"Structural Basis for Rab8a Recruitment of RILPL2 via LRRK2 Phosphorylation of Switch 2","volume":"28","author":"Purlyte","year":"2020","journal-title":"Structure"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1042\/BCJ20190315","article-title":"Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson\u2019s disease patients","volume":"476","author":"Fdez","year":"2019","journal-title":"Biochem. J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/bi100157u","article-title":"Membrane Localization of LRRK2 Is Associated with Increased Formation of the Highly Active LRRK2 Dimer and Changes in Its Phosphorylation","volume":"49","author":"Berger","year":"2010","journal-title":"Biochemistry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embj.201798099","article-title":"Rab29 activation of the Parkinson\u2019s disease-associated LRRK2 kinase","volume":"37","author":"Purlyte","year":"2017","journal-title":"EMBO J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1042\/BCJ20200458","article-title":"Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity","volume":"477","author":"Kalogeropulou","year":"2020","journal-title":"Biochem. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e87098","DOI":"10.7554\/eLife.87098","article-title":"Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson\u2019s disease-linked LRRK2 kinase","volume":"12","author":"Dhekne","year":"2023","journal-title":"eLife"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"105192","DOI":"10.1016\/j.jbc.2023.105192","article-title":"Endogenous Rab38 regulates LRRK2\u2019s membrane recruitment and substrate Rab phosphorylation in melanocytes","volume":"299","author":"Unapanta","year":"2023","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nchembio.538","article-title":"Characterization of a selective inhibitor of the Parkinson\u2019s disease kinase LRRK2","volume":"7","author":"Deng","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/brain\/awy147","article-title":"Is Parkinson\u2019s disease a lysosomal disorder?","volume":"141","author":"Klein","year":"2018","journal-title":"Brain"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"273ra15","DOI":"10.1126\/scitranslmed.aaa3634","article-title":"Effect of selective LRRK2 kinase inhibition on nonhuman primate lung","volume":"7","author":"Fuji","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41591-020-0893-5","article-title":"The effect of LRRK2 loss-of-function variants in humans","volume":"26","author":"Whiffin","year":"2020","journal-title":"Nat. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1042\/BCJ20210375","article-title":"Impact of Type II LRRK2 inhibitors on signaling and mitophagy","volume":"478","author":"Tasegian","year":"2021","journal-title":"Biochem. J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.115.227587","article-title":"MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition","volume":"355","author":"Fell","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"eabj2658","DOI":"10.1126\/scitranslmed.abj2658","article-title":"Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson\u2019s disease","volume":"14","author":"Jennings","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e2315171120","DOI":"10.1073\/pnas.2315171120","article-title":"Localization of PPM1H phosphatase tunes Parkinson\u2019s disease-linked LRRK2 kinase-mediated Rab GTPase phosphorylation and ciliogenesis","volume":"120","author":"Yeshaw","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"EMBR202152675","DOI":"10.15252\/embr.202152675","article-title":"Structural basis for the specificity of PPM1H phosphatase for Rab GTPases","volume":"22","author":"Berndsen","year":"2021","journal-title":"EMBO Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1242\/jcs.204529","article-title":"L-leucyl-L-leucine methyl ester does not release cysteine cathepsins to the cytosol but inactivates them in transiently permeabilized lysosomes","volume":"130","author":"Repnik","year":"2017","journal-title":"J. Cell Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e202310150","DOI":"10.1083\/jcb.202310150","article-title":"A STING\u2013CASM\u2013GABARAP pathway activates LRRK2 at lysosomes","volume":"224","author":"Ferguson","year":"2025","journal-title":"J. Cell Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"EMBJ201899753","DOI":"10.15252\/embj.201899753","article-title":"ESCRT-mediated lysosome repair precedes lysophagy and promotes cell survival","volume":"37","author":"Radulovic","year":"2018","journal-title":"EMBO J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"eaar5078","DOI":"10.1126\/science.aar5078","article-title":"Triggered recruitment of ESCRT machinery promotes endolysosomal repair","volume":"360","author":"Skowyra","year":"2018","journal-title":"Science"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41467-022-29481-4","article-title":"Ca2+-activated sphingomyelin scrambling and turnover mediate ESCRT-independent lysosomal repair","volume":"13","author":"Niekamp","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2016.06.037","article-title":"Endosome-ER Contacts Control Actin Nucleation and Retromer Function through VAP-Dependent Regulation of PI4P","volume":"166","author":"Dong","year":"2016","journal-title":"Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.1038\/ncomms11808","article-title":"Cholesterol and ORP1L-mediated ER contact sites control autophagosome transport and fusion with the endocytic pathway","volume":"7","author":"Wijdeven","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1083\/jcb.201811139","article-title":"ATG2 transports lipids to promote autophagosome biogenesis","volume":"218","author":"Valverde","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/15548627.2015.1067364","article-title":"Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease","volume":"11","author":"Dion","year":"2015","journal-title":"Autophagy"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.bbamcr.2013.07.020","article-title":"Inhibition of LRRK2 kinase activity stimulates macroautophagy","volume":"1833","author":"Manzoni","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1093\/hmg\/ddv314","article-title":"Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression","volume":"24","author":"Henry","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Madureira, M., Connor-Robson, N., and Wade-Martins, R. (2020). LRRK2: Autophagy and Lysosomal Activity. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.00498"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41580-019-0185-4","article-title":"Lysosomes as dynamic regulators of cell and organismal homeostasis","volume":"21","author":"Ballabio","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e2303789120","DOI":"10.1073\/pnas.2303789120","article-title":"LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition","volume":"120","author":"Yadavalli","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson\u2019s Disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/brain\/awv179","article-title":"Glucocerebrosidase activity in Parkinson\u2019s disease with and without GBA mutations","volume":"138","author":"Alcalay","year":"2015","journal-title":"Brain"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1038\/s41467-019-13413-w","article-title":"LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson\u2019s disease patients","volume":"10","author":"Ysselstein","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.celrep.2016.10.062","article-title":"BORC Functions Upstream of Kinesins 1 and 3 to Coordinate Regional Movement of Lysosomes along Different Microtubule Tracks","volume":"17","author":"Guardia","year":"2016","journal-title":"Cell Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1083\/jcb.201703094","article-title":"A Ragulator\u2013BORC interaction controls lysosome positioning in response to amino acid availability","volume":"216","author":"Pu","year":"2017","journal-title":"J. Cell Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1038\/ncomms4828","article-title":"Mutation in VPS35 associated with Parkinson\u2019s disease impairs WASH complex association and inhibits autophagy","volume":"5","author":"Zavodszky","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41586-022-05164-4","article-title":"A phosphoinositide signalling pathway mediates rapid lysosomal repair","volume":"609","author":"Tan","year":"2022","journal-title":"Nature"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e87255","DOI":"10.7554\/eLife.87255","article-title":"Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes","volume":"12","author":"Wang","year":"2023","journal-title":"eLife"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"eadj1205","DOI":"10.1126\/sciadv.adj1205","article-title":"Parkinson\u2019s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B","volume":"9","author":"Pal","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/jmedgenet-2016-103756","article-title":"Identification of biallelic LRRK1 mutations in osteosclerotic metaphyseal dysplasia and evidence for locus heterogeneity","volume":"53","author":"Iida","year":"2016","journal-title":"J. Med. Genet."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"jcs228809","DOI":"10.1242\/jcs.228809","article-title":"LRRK1 phosphorylation of Rab7 at S72 links trafficking of EGFR-containing endosomes to its effector RILP","volume":"132","author":"Hanafusa","year":"2019","journal-title":"J. Cell Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1042\/BCJ20200937","article-title":"Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms","volume":"478","author":"Malik","year":"2021","journal-title":"Biochem. J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41594-023-01109-1","article-title":"Structure of LRRK1 and mechanisms of autoinhibition and activation","volume":"30","author":"Reimer","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1038\/s41467-023-40532-2","article-title":"Structure and regulation of full-length human leucine-rich repeat kinase 1","volume":"14","author":"Metcalfe","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1042\/BCJ20220308","article-title":"PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain","volume":"479","author":"Malik","year":"2022","journal-title":"Biochem. J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00239-008-9122-4","article-title":"Ancient Origin of the Parkinson Disease Gene LRRK2","volume":"67","year":"2008","journal-title":"J. Mol. Evol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1128\/MCB.00085-15","article-title":"Leucine-Rich Repeat Kinase 1 Regulates Autophagy through Turning on TBC1D2-Dependent Rab7 Inactivation","volume":"35","author":"Toyofuku","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"jcs260395","DOI":"10.1242\/jcs.260395","article-title":"The ULK complex\u2013LRRK1 axis regulates Parkin-mediated mitophagy via Rab7 Ser-72 phosphorylation","volume":"135","author":"Fujita","year":"2022","journal-title":"J. Cell Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7606\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:32:29Z","timestamp":1788251549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":112,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177606"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177606","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}